
As an Amazon Associate and affiliate partner, Menrva Books earns from qualifying purchases. Learn more
During the last decade, knowledge about cholestatic liver disease and concomitant diseases, such as ulcerative colitis, cholangio- and hepatocellular carcinoma, pancreas and colon cancer, has increased considerably. Studies on ursodeoxycholic acid treatment alone or in combination with immunosuppressive compounds and their positive effects on biliary liver disease as well as on so-called overlap syndromes or intestinal tumors are published in increasing numbers, and stimulate discussion on whether or not ursodeoxycholic acid is able to improve the general condition and/or life expectancy of patients. On the other hand, genetics, aetiological and pathogenetic aspects are still difficult to comprehend, but are the absolute prerequisite for the development of better treatment options. This book is the proceedings of Falk Symposium No. 136 (Part I of the XII Falk Liver Week, held in Freiburg, Germany, on October 15-16, 2003), and contains stimulating, exciting and controversial papers on clinical and also basic research at the highest scientific level.
The book investigates the significant advancements in understanding and treating cholestatic liver diseases, alongside related conditions, and explores the ongoing debate surrounding the efficacy of ursodeoxycholic acid. The proceedings from Falk Symposium No. 136 address the considerable increase in knowledge regarding cholestatic liver diseases and their comorbidities, such as inflammatory bowel disease and various cancers. It highlights studies on ursodeoxycholic acid, both alone and in combination with immunosuppressants, examining its impact on biliary diseases and overlap syndromes, while also acknowledging the complexities in understanding genetic and pathogenetic aspects crucial for developing improved therapies. The papers presented cover clinical and basic research at a high scientific level, aiming to stimulate discussion and provide new perspectives.
This volume, comprising papers from Falk Symposium No. 136, presents cutting-edge research on cholestatic liver diseases. The discussions likely reflect a high scientific standard, focusing on both established and emerging therapeutic strategies. The inclusion of controversial papers suggests a dynamic exchange of ideas among leading researchers in the field. The book serves as a valuable resource for clinicians and scientists seeking to deepen their understanding of these complex liver conditions and their management.
Page Count:
396
Publication Date:
2004-06-30
Publisher:
Springer Science & Business Media
ISBN-10:
0792387937
ISBN-13:
9780792387930
No comments yet. Be the first to share your thoughts!